• Certified Lab Equipment & Reagents
  • Fast Dispatch on In-Stock Items
  • Expert Scientific Support

Product details

Laminin Receptor / RPSA (Marker of Metastatic Potential) (RPSA/2699), 0.2mg/mL

Catalog number BNUB2699-100

Price for BNUB2699-100

Sign In for Pricing

Size / count 1x 100 µL

About this product

Laminins, a family of extracellular matrix glycoproteins, are the major non-collagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Many of the effects of laminin are mediated through interactions with cell surface receptors. These receptors include members of the integrin family, as well as non-integrin laminin-binding proteins. This gene encodes a high-affinity, non-integrin family, laminin receptor 1. Reportedly, level of laminin receptor transcript is higher in colon carcinoma tissue and lung cancer cell line than their normal counterparts. Also, there is a correlation between the upregulation of this polypeptide in cancer cells and their invasive and metastatic phenotype. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

Specifications

Catalog number
BNUB2699-100
Size / count
1x 100 µL
Dry ice
No
Hazardous
No
Discontinued
No
CAS Number
9007-83-4
Synonyms
34/67kDa Laminin Receptor; 37kDa Laminin Receptor precursor; 37/67kDa Laminin Receptor; 37LRP; 40S Ribosomal Protein SA; 67kDa Laminin Receptor; 67LR; Colon Carcinoma Laminin-binding Protein; LAMBR; Laminin receptor 1; Laminin-binding Protein precursor p40; LAMR1; LBP/p40; LRP/LR; Multidrug resistance-associated protein MGr1-Ag; NEM/1CHD4; Ribosomal Protein SA (RPSA)
UNSPSC
41116161
UNSPSC Description
Primary and secondary antibodies for multiple methodology immunostaining detection application
Gene Name
RPSA
Gene ID
3921
NCBI Gene ID
449909
UniProt
P08865
Swiss Prot
P08865
Host
Mouse
Species Reactivity
Human
Reactivity
Laminin Receptor|RPSA
Immunogen
Recombinant full-length human RPSA protein
Target Antigen
Laminin Receptor | RPSA
Clonality
Monoclonal
Clone
RPSA/2699
Type
Primary
Source
Animal
Origin
Animal
Applications
Flow (verified) |IF (verified)
Positive Control
MCF-7, MDA-MB-453, SK-BR3, THP1, HL60, HeLa or HEK293 cells. Breast, Colon or Ovarian Carcinoma, Tonsil.
Stability
2 years
Concentration
0.2 mg/mL
Buffer
PBS, 0.05% BSA, 0.05% azide
Molecular Weight
37-67 kDa
Shipping Conditions
RT (ND)
Storage Conditions
Stable at room temperature or 37°C (98°F) for 7 days.
Shelf Life
Guaranteed for at least 24 months from date of receipt when stored as recommended
Fragment
IgG1, kappa
Species
Mus musculus (mouse), BSA from bovine serum (Bos taurus) or recombinant BSA produced in Chinese hamster ovary cells.
Classification
PBS, 0.05% BSA, 0.05% sodium azide (CAS 26628-22-8)
Conjugate
Purified, with BSA

Frequently Asked Questions

What is the catalog number for Laminin Receptor / RPSA (Marker of Metastatic Potential) (RPSA/2699), 0.2mg/mL?

The catalog number for Laminin Receptor / RPSA (Marker of Metastatic Potential) (RPSA/2699), 0.2mg/mL is BNUB2699-100.

What sizes are available for Laminin Receptor / RPSA (Marker of Metastatic Potential) (RPSA/2699), 0.2mg/mL?

Laminin Receptor / RPSA (Marker of Metastatic Potential) (RPSA/2699), 0.2mg/mL is available in the following size(s): 1x 100 µL.

Is Laminin Receptor / RPSA (Marker of Metastatic Potential) (RPSA/2699), 0.2mg/mL in stock?

Laminin Receptor / RPSA (Marker of Metastatic Potential) (RPSA/2699), 0.2mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures Laminin Receptor / RPSA (Marker of Metastatic Potential) (RPSA/2699), 0.2mg/mL?

Laminin Receptor / RPSA (Marker of Metastatic Potential) (RPSA/2699), 0.2mg/mL is manufactured by Biotium.

What is the estimated delivery time for Laminin Receptor / RPSA (Marker of Metastatic Potential) (RPSA/2699), 0.2mg/mL?

Estimated delivery time for Laminin Receptor / RPSA (Marker of Metastatic Potential) (RPSA/2699), 0.2mg/mL is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for Laminin Receptor / RPSA (Marker of Metastatic Potential) (RPSA/2699), 0.2mg/mL?

The safety data sheet for Laminin Receptor / RPSA (Marker of Metastatic Potential) (RPSA/2699), 0.2mg/mL is available here: https://cdn.gentaur.com/products/37/68dd0298061270361e100cff/msds/bnub2699-100.pdf.

What is Laminin Receptor / RPSA (Marker of Metastatic Potential) (RPSA/2699), 0.2mg/mL used for?

Laminins, a family of extracellular matrix glycoproteins, are the major non-collagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Many of the

Is this kit compatible with automated liquid handling platforms?

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

What applications has this product been validated for?

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

How do I reconstitute this lyophilized product?

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

You Might Also Like
CD81 / TAPA-1 (1.3.3.22), CF647 conjugate, 0.1mg/mL
CD81 / TAPA-1 (1.3.3.22), CF647 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC470391-100
TGF-beta (1D11.16.8), CF740 conjugate, 0.1mg/mL
TGF-beta (1D11.16.8), CF740 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC740977-500
CD171 / L1CAM (L1 Cell Adhesion Molecule) (UJ127), CF594 conjugate, 0.1mg/mL
CD171 / L1CAM (L1 Cell Adhesion Molecule) (UJ127), CF594 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC940679-500
ACTH (Adrenocorticotrophic Hormone) (AH26), CF740 conjugate, 0.1mg/mL
ACTH (Adrenocorticotrophic Hormone) (AH26), CF740 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC740026-500
CD3e (B-B12), CF640R conjugate, 0.1mg/mL
CD3e (B-B12), CF640R conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC401052-100
FOXP3 (3G3), CF488A conjugate, 0.1mg/mL
FOXP3 (3G3), CF488A conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC880645-100
CD1a (O10 + C1A/711), CF647 conjugate, 0.1mg/mL
CD1a (O10 + C1A/711), CF647 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC470717-500
WT1 (Wilm's Tumor 1) (WT1/857), CF405S conjugate, 0.1mg/mL
WT1 (Wilm's Tumor 1) (WT1/857), CF405S conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC040857-100